According to Masimo's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.51153. At the end of 2023 the company had a P/S ratio of 3.02.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.02 | -20.84% |
2022 | 3.82 | -70.72% |
2021 | 13.0 | 1% |
2020 | 12.9 | 42.75% |
2019 | 9.05 | 36.27% |
2018 | 6.64 | 22.38% |
2017 | 5.43 | 12.57% |
2016 | 4.82 | 45.5% |
2015 | 3.31 | 40.78% |
2014 | 2.35 | -22.19% |
2013 | 3.02 | 23.89% |
2012 | 2.44 | -4.42% |
2011 | 2.55 | -39.54% |
2010 | 4.22 | -15.99% |
2009 | 5.03 | -2% |
2008 | 5.13 | -36.89% |
2007 | 8.13 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 4.82 | 37.35% | ๐บ๐ธ USA |
General Electric GE | 2.46 | -29.93% | ๐บ๐ธ USA |
ResMed RMD | 5.80 | 65.18% | ๐บ๐ธ USA |
Cardinal Health CAH | 0.1193 | -96.60% | ๐บ๐ธ USA |
Universal Forest Products
UFPI | 0.9432 | -73.14% | ๐บ๐ธ USA |
CONMED CNMD | 1.76 | -49.93% | ๐บ๐ธ USA |
Owens & Minor
OMI | 0.1783 | -94.92% | ๐บ๐ธ USA |
Philips PHG | 0.9277 | -73.58% | ๐ณ๐ฑ Netherlands |